Insmed | INSM - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Cytokinetics USD 248.2M 993K 2026-06
DBV Technologies USD 0 0 2025-03
Gilead Sciences USD 20.86B 1.27B 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
Insmed USD 543.51M 1.3M 2026-06
Novartis USD 37.45B 7.86B 2026-03
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12